Literature DB >> 12194383

Genetics of primary dystonia.

C Klein1, X O Breakefield, L J Ozelius.   

Abstract

Currently, at least 12 types of dystonia can be distinguished on a genetic basis. Advances in the molecular genetics of dystonia have led to the recent identification of a 3-bp deletion in the DYT1 gene, causing early-onset generalized torsion dystonia (TD), and to the detection of mutations in the GTP cyclohydrolase I and the tyrosine hydroxylase genes causing dopa-responsive dystonia (DYT5). A missense change in the D2 dopamine receptor has been shown to be associated with myoclonus-dystonia in one family. In addition, six other dystonia gene loci have been mapped to chromosomal regions, including a locus for a mixed dystonia phenotype (DYT6), one form of focal dystonia (DYT7), two types of paroxysmal dystonia (DYT8, DYT9), X-linked dystonia-parkinsonism (DYT3), and rapid-onset dystonia parkinsonism (DYT12). No positive linkage studies have as yet been reported for autosomal recessive TD (DYT2) and in several other large families with various types of dominantly inherited TD (DYT4). It may be anticipated that the traditional clinical and etiological classifications of dystonia will increasingly be replaced by a genetic one and that the identification of more dystonia genes may lead to a better understanding of these largely nondegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12194383     DOI: 10.1055/s-2008-1040843

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  7 in total

1.  In vivo neurochemistry of primary focal hand dystonia: a magnetic resonance spectroscopic neurometabolite profiling study at 3T.

Authors:  Priyantha Herath; Cecile Gallea; Jan Willem van der Veen; Silvina G Horovitz; Mark Hallett
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

2.  Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant.

Authors:  Gonzalo E Torres; Ava L Sweeney; Jean-Martin Beaulieu; Pullani Shashidharan; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

3.  White matter abnormalities in dystonia normalize after botulinum toxin treatment.

Authors:  Anne J Blood; David S Tuch; Nikos Makris; Miriam L Makhlouf; Lewis R Sudarsky; Nutan Sharma
Journal:  Neuroreport       Date:  2006-08-21       Impact factor: 1.837

Review 4.  Neuroimaging and therapeutics in movement disorders.

Authors:  Thomas Eckert; David Eidelberg
Journal:  NeuroRx       Date:  2005-04

Review 5.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  A role for cerebellum in the hereditary dystonia DYT1.

Authors:  Rachel Fremont; Ambika Tewari; Chantal Angueyra; Kamran Khodakhah
Journal:  Elife       Date:  2017-02-15       Impact factor: 8.140

Review 7.  Treating complex movement disorders in children with cerebral palsy.

Authors:  Claire Lundy; Daniel Lumsden; Charlie Fairhurst
Journal:  Ulster Med J       Date:  2009-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.